Chimera Investment Co. (NYSE:CIM – Get Rating) shares dropped 8.2% during mid-day trading on Thursday following a weaker than expected earnings announcement. The stock traded as low as $9.29 and last traded at $9.30. Approximately 62,553 shares changed hands during trading, a decline of 97% from the average daily volume of 1,817,389 shares. The stock had previously closed at $10.13.
The real estate investment trust reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.06). Chimera Investment had a negative net margin of 8.93% and a positive return on equity of 12.47%. The firm had revenue of $116.89 million during the quarter, compared to analysts’ expectations of $131.19 million. During the same quarter last year, the firm earned $0.54 EPS. The business’s revenue for the quarter was down 32.1% compared to the same quarter last year.
Wall Street Analyst Weigh In
CIM has been the topic of a number of recent research reports. Credit Suisse Group lowered their target price on Chimera Investment to $9.50 in a research note on Friday, July 22nd. Barclays decreased their price target on Chimera Investment from $11.00 to $9.00 and set an “underweight” rating for the company in a research note on Monday, July 18th.
Institutional Trading of Chimera Investment
Chimera Investment Stock Performance
The firm has a 50 day moving average of $9.30 and a two-hundred day moving average of $10.92. The stock has a market cap of $2.20 billion, a P/E ratio of -14.31 and a beta of 1.05. The company has a debt-to-equity ratio of 3.45, a quick ratio of 6.05 and a current ratio of 6.05.
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of residential, commercial mortgage loans, and other real estate related securities.
See Also
- Get a free copy of the StockNews.com research report on Chimera Investment (CIM)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.